Journal of Applied Physiology Millar Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 98: 680-689, 2005. First published October 8, 2004; doi:10.1152/japplphysiol.00924.2004
8750-7587/05 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
98/2/680    most recent
00924.2004v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finsen, A. V.
Right arrow Articles by Sjaastad, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finsen, A. V.
Right arrow Articles by Sjaastad, I.

Echocardiographic parameters discriminating myocardial infarction with pulmonary congestion from myocardial infarction without congestion in the mouse

Alexandra Vanessa Finsen,1,2 Geir Christensen,1,2 and Ivar Sjaastad1,2,3

1Institute for Experimental Medical Research, Ullevaal University Hospital, 2Center for Heart Failure Research, University of Oslo, and 3Department of Cardiology, Ullevaal University Hospital, Oslo, Norway

Submitted 26 August 2004 ; accepted in final form 1 October 2004


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Our aim was to establish parameters describing systolic and diastolic function in mice after myocardial infarction (MI) that distinguish MI with pulmonary congestion from MI without congestion. Echocardiography, left ventricular (LV) catheterization, and infarct size measurements were performed on days 3, 5, 7, and 14 after ligation of the left coronary artery in C57BL/6 mice. Sham-operated mice were used as controls (Sham). MI mice with lung weight normalized to tibial length >125% of the average in the corresponding Sham group were considered to have pulmonary congestion (MIchf). MI mice with a smaller increase were called MI nonfailing (MInf). An infarct >40% of total LV circumference measured in two-dimensional long axis distinguished MIchf from MInf on both an average and an individual basis. Mean maximum rate of rise of LV pressure, LV fractional shortening, and posterior wall shortening velocity were significantly lower in MIchf compared with Sham at all time points and to MInf at 7 days. The diastolic parameters mitral flow deceleration velocity, LV end-diastolic pressure, and maximum rate of decline in LV pressure (LVdP/dtmin) discriminated the MIchf groups from Sham at all time points. Mitral flow deceleration velocity and LVdP/dtmin separated MIchf from MInf at 7 days. In addition to distinguishing all the groups on an average basis, left atrial diameter distinguished all MIchf animals from Sham and MInf. In conclusion, significantly increased left atrial diameter and infarct size >40% of total LV circumference may serve as major criteria for heart failure with pulmonary congestion after MI in mice.

hemodynamic measurements; left ventricular function; heart failure


MYOCARDIAL INFARCTION (MI) remains a major cause of cardiac death, and congestive heart failure (CHF) is another serious outcome of MI. Despite substantial research efforts, the mechanisms of the transition to CHF are far from elucidated. The mouse model of MI is of particular relevance in studies of postinfarction CHF, because the model offers the opportunity to study the mechanisms of CHF in genetically engineered mice. In the mouse postinfarction model, some studies (1, 6, 11, 13, 17) have investigated the development of left ventricular (LV) remodeling, using a combination of in vivo and ex vivo methods. However, none of these studies has established parameters that reliably discriminate between MI mice with and without CHF. Reliable parameters for identification of mice with CHF on an individual basis may also be very useful in other models, such as genetically modified mice showing signs of reduced cardiac function. Although such parameters have been established in humans (10) and larger animals (14), those parameters may not be useful in the mouse because of the small size and high heart rate.

Heart failure can be categorized as systolic and/or diastolic. Systolic heart failure is characterized by reduced LV contractility, dilatation of the left ventricle, and a reduction in ejection fraction (EF). In postinfarction CHF in both mice and humans, cardiac systolic performance is often impaired, but diastolic dysfunction might also be present. Reduced diastolic performance is associated with reduced relaxation and ventricular filling because of reduced LV compliance leading to elevated LV filling pressure. In postinfarction CHF, the observed elevation of LV filling pressure can be explained by both systolic and diastolic dysfunction. This may be reflected in an elevated LV end-diastolic pressure (LVEDP). The increased LV filling pressure results in elevation of the pressure in the left atrium and in the pulmonary circulation, which may result in distension of the left atrium and pulmonary congestion.

There are several ways of assessing LV function with echocardiographic and LV pressure measurements. LV systolic performance is often measured as EF or as myocardial shortening velocity in humans (10). Although the LV EF reflects myocardial contractility, it has limited value when afterload is abnormal and in valvular disease. LV end-systolic and end-diastolic volumes and dimensions also reflect systolic and contractile performance when afterload is normal. Furthermore, the maximum rate of rise of LV pressure (LVdP/dtmax) is highly sensitive to changes in contractility as seen in CHF, but only at constant LVEDP. LV diastolic performance can be assessed by analysis of LV filling patterns (8, 10). In particular, prolonged deceleration time of early transmitral filling and reduced E/A ratio are useful parameters, because they reflect abnormal LV relaxation and/or diastolic distensibility (15). The maximum rate of decline in LV pressure (LVdP/dtmin), however, is strongly influenced by the pressure at the time of aortic valve closure and is not a good measure of the rate of isovolumetric relaxation. Reduced LV diastolic performance and elevated LVEDP may result in increased left atrial pressure, and dilatation of the left atrium often ensues in humans (10) and larger animals (14). Thus we suggest that left atrial diameter (LAD) might also be a useful parameter in mice.

In the present study, cardiac function and infarct size were assessed by means of echocardiography and invasive LV pressure measurements 3, 5, 7, and 14 days after induction of MI in mice. MI mice with pulmonary congestion were compared with both MI mice without pulmonary congestion and sham-operated mice (Sham).


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1996) and was approved by the Norwegian National Animal Research Committee.

Animal model.   MI was induced in 8-wk-old female C57BL/6 mice as previously described (16). Briefly, after being anesthetized with intravenous tail injections of 0.2 ml propofol (10 mg/ml), the animals were tracheotomized and connected to a rodent ventilator (model 874092, B. Braun, Melsungen, Germany) and given a mixture of 1.8–2.2% isoflurane and ~98% oxygen. A thoracotomy was performed in the third intercostal space on the left side, and the left coronary artery was ligated. Sham-operated animals underwent the same procedure except ligation of the artery. At 3, 5, 7, or 14 days after primary surgery, the animals were again anesthetized and intubated before echocardiography, and LV pressure measurements were carried out, as described below. Then the hearts were removed and blotted dry. The right ventricle and atria were removed. In the infarcted hearts, a cut was made longitudinally through the LV free wall from the base to the apex, and, to enable proper unfolding of the infarcted area, one or two further longitudinal cuts were made in the noninfarcted tissue, if necessary. The unfolded endocardia were photographed with a digital camera (Nikon Coolpix 4500). Total endocardial area and infarcted area were then traced (Fig. 1), and infarct size as percentage of total area was calculated by use of ImageJ 1.32j software (Wayne Rasband, National Institute of Mental Health). The LV, infarcted area, right ventricular free wall, and lungs were weighed and normalized to tibial length. A priori we decided that MI mice with lung weight (LW) higher than all Sham animals in the corresponding group should be considered to have pulmonary congestion. No Sham mice had a LW >125% of the mean in their group. A 125% cutoff was close to 4 standard deviations above the mean in the Sham groups. Therefore, MI mice with a LW normalized to tibial length (LW/TL) >125% of average in the corresponding Sham group were considered to have pulmonary congestion subsequent to an MI and were called MIchf. MI mice with a LW/TL <125% compared with Sham were considered not to have a significant pulmonary congestion, and this group was called MI nonfailing (MInf). The average LW/TL values in the MIchf groups were 36–102% higher than in Sham at the various time points. Furthermore, the LW/TL was 78% higher in MIchf compared with MInf at 7 days (P < 0.05), but MInf was not significantly different from Sham.



View larger version (117K):
[in this window]
[in a new window]
 
Fig. 1. Representative photography of the endocardium from an infarcted mouse heart. Total endocardial area and infarct area are indicated.

 
Echocardiography.   In vivo heart function was evaluated by echocardiography using a fully digitized VIVID 7 system (GE Vingmed Ultrasound, Horten, Norway) with an i13L 13-MHz linear array transducer designed for the examination of small rodents. The mice were examined in the supine position with closed chests, and the transducer was gently placed in the left parasternal position, in principle as previously described (14). The images were transferred to a computer and analyzed with EchoPac PC 3.0x software (General Electric). Three representative cycles were analyzed and averaged. Two-dimensional (2D) images of the LV were obtained both in long and short axes at a frame rate of >200/s. Short axis recordings were obtained at the level of the papillary muscle. M-mode tracings were recorded at the level of both the papillary muscles and the aortic valves, with 2D guidance. LV wall thickness and cavity dimensions were measured through the largest diameter of the ventricle (14), both in systole and diastole. LV fractional shortening (LVFS), in percent, was calculated by using the following formula

where LVDd is LV diameter in diastole, and LVDs is LV diameter in systole.

LV circumference and infarcted area were measured in 2D long axis, by freehand tracing of the outer contour of the LV endocardium from LV outflow tract (LVOT) to the LV-left atrial commissure in diastole. Posterior wall shortening velocity (PWSV) and posterior wall relaxation velocity (PWRV) were measured in M-mode by applying a line parallel to the second endocardial contour. Aortic diameter and LAD were measured both in 2D long axis and M-mode.

Doppler measurements.   Doppler recordings were obtained in the left parasternal long axis position. Pulsed Doppler was performed at the level of the LVOT, the right ventricular outflow tract (RVOT), and the mitral valve tips. The Doppler signal from RVOT was almost parallel to the blood flow and therefore measured flow reliably. In LVOT, however, the flow direction deviated ~20° from being parallel to the chest wall, and the Doppler beam had an angle of 70° to the chest wall. The deviation between the LVOT flow direction and the ultrasound beam, ~50°, was corrected digitally online to avoid underestimation of LVOT flow. Mitral flow velocity was measured at the tips of the mitral valves, with the Doppler beam directed parallel to the flow. Cardiac output (CO) was calculated in LVOT by using the following equation

where VTI is the velocity time integral, HR is heart rate, and diameter is measured in LVOT.

LV pressure measurements.   Immediately after echocardiography was finished, a 1.4-Fr microtip pressure transducer catheter (SPR-671, Millar Instruments, Houston, TX) was introduced into the left ventricle through the right carotid artery for measurements of LV pressures and calculations of its maximal positive and negative first derivatives. Data recorded from 10–15 consecutive beats were analyzed.

Statistics.   Data are expressed as group means ± SE, unless indicated otherwise. Comparisons between groups were made using two-way ANOVA and Newman-Keuls post hoc test in Statistica 6.0. Overall changes with time were compared with the value at 3 days in the same group. By convention (12), inter- and intrascorer reliability was expressed as the average difference between the scorers ± 2 SD, corresponding to mean and "limits of agreement" in the Bland-Altman analysis (2). Average absolute difference between the scorers was expressed as means ± SD. Between-scorer difference was tested with a paired t-test. Differences were considered significant for P < 0.05.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Animal characteristics.   Ligation of the left coronary artery induced an infarct size which in the MIchf group included >30% of the LV area and >40% of the LV circumference (Table 1). Both methods of infarct size estimation revealed significantly larger infarcts in MIchf than in MInf at 7 days, 120 and 43%, respectively. There was a positive correlation between the two methods of calculating infarct size (r2 = 0.79) (Fig. 2). Most animals in the MIchf group showed overt clinical signs of CHF, such as tachypnea, strained respiration, and macroscopically congested lungs. LV weight (LVW) normalized to tibial length (LVW/TL) was significantly increased in MIchf compared with Sham at days 3, 7, and 14, and compared with MInf at 7 days. Right ventricular weight (RVW) normalized to tibial length (RVW/TL) was similarly increased in MIchf compared with Sham at 7 and 14 days and compared with MInf at 7 days. In MIchf both LVW/TL and RVW/TL were higher at days 7 and 14 compared with day 3 (P < 0.05).


View this table:
[in this window]
[in a new window]
 
Table 1. Animal characteristics

 


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 2. Scatterplot of infarction sizes at 7 days, showing correlation between 2 methods of measuring infarction size (r2 = 0.79). Infarct circumference was measured as distribution of infarction as percentage of total left ventricular (LV) circumference in 2-dimensional (2D) long axis. Infarct area was measured as percentage of total endocardial area. {circ}, Myocardial infarction (MI) animals with pulmonary congestion (MIchf); {triangleup}, nonfailing MI (MInf) animals.

 
HR and LV pressure measurements.   HR was not significantly different between MIchf and Sham at any time point (Table 2); neither was any significant change with time observed. LVdP/dtmax (Fig. 3A) and LV systolic pressure were overall reduced in MIchf compared with Sham (35–53% and 11–23%, respectively). LVdP/dtmax was 32% lower in MIchf than in MInf (P < 0.05). Furthermore, it was found that LVdP/dtmin (Fig. 4A) was significantly lower (29–48%) in MIchf compared with Sham at all time points. Mean LVdP/dtmin in the MInf group was significantly higher (32%) than in MIchf and significantly lower (21%) than in Sham. LVEDP was significantly increased (122–308%) in the MIchf groups compared with Sham. However, there was no significant difference in LVEDP between MInf and the other groups at 7 days.


View this table:
[in this window]
[in a new window]
 
Table 2. Heart rates and left ventricular pressure measurements

 


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3. Systolic parameters. A: peak rate of LV pressure increase (LVdP/dtmax). B: LV diameter in diastole (LVDd) measured in 2D. C: LV fractional shortening (LVFS) measured in 2D. D: posterior wall (PW) shortening velocity (PWSV) measured in M-mode by applying a line parallel to the second endocardial contour. Values are means ± SE for the various time points. d, Days. {circ}, MIchf; {triangleup}, MInf; {bullet}, Sham. *P < 0.05 for MIchf vs. Sham; {dagger}P < 0.05 for MIchf vs. MInf; {ddagger}P < 0.05 for MInf vs. Sham.

 


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 4. Diastolic parameters. A: peak rate of LV pressure decline (LVdP/dtmin). B: PW relaxation velocity (PWRV) measured in M-mode by applying a line parallel to the second endocardial contour. C: mitral flow deceleration velocity (Mit dec). Values are means ± SE for the various time points. {circ}, MIchf; {triangleup}, MInf; {bullet}, Sham. *P < 0.05 for MIchf vs. Sham; {dagger}P < 0.05 for MIchf vs. MInf.

 
Echocardiographic measurements.   We found a significant increase in LV diameter in diastole in MIchf compared with Sham at all time points (39–61%) (Fig. 3B) and also compared with MInf (29%) at 7 days (Table 3). Furthermore, LV diameter in the MIchf groups showed a gradual and significant increase with time compared with that at 3 days. Representative 2D and M-mode images of these changes are shown in Fig. 5. As a sign of systolic dysfunction, LVFS (Fig. 3C) was significantly decreased in MIchf compared with Sham at all time points (63–75%). LVFS in the MInf group was significantly lower than Sham (54%), but not different from MIchf. Posterior wall thickening, which is considered to be another systolic parameter, was not significantly different in MIchf and MInf compared with Sham. As a further sign of decreased systolic function, though, we found a reduction in PWSV in MIchf compared with Sham at all time points (14–31%, Fig. 3D, P < 0.05) and compared with MInf at 7 days (14%, P < 0.05). PWRV, which is a diastolic parameter, did not show any significant difference between the groups at any time points (Fig. 4B). LAD, which may reflect increased LV diastolic filling pressure, was significantly increased in MIchf compared with Sham at all time points (43–77%) (Table 3). Also, there was a significant increase in LAD in MIchf at 7 and 14 days compared with 3 days. The MInf group had a significantly smaller LAD compared with MIchf (44%), but LAD was 23% larger than Sham (P < 0.05). There was a good correlation between LAD measured in 2D and M-mode (r2 = 0.95).


View this table:
[in this window]
[in a new window]
 
Table 3. Echocardiographic measurements

 


View larger version (131K):
[in this window]
[in a new window]
 
Fig. 5. Echocardiographic recordings. First row: 2D long-axis frames showing dilatation of the LV cavity in MInf (middle column) and MIchf (right column) compared with Sham (left column). In MInf and MIchf the infarction (INF) can be seen in the septum/anterior wall and apex. The papillary muscle is seen above the PW. The left atrium (LA) in MIchf is dilated compared with MInf and Sham. Second row: explanatory tracings of the 2D long-axis frames above. Third row: M-mode tracings from the LV showing that the septum is thin and does not contract in MIchf. Contraction is also depressed in MInf compared with Sham. The LV cavity is dilated in MIchf, and PW shortening velocity is markedly reduced in MIchf compared with Sham. Bars indicate thickness of interventricular septum (IVS) and PW. Fourth row: M-mode tracings showing the aorta (Ao) and LA. LA diameter is increased in MIchf compared with both MInf and Sham. Bars indicate diameter of LA.

 
Doppler measurements.   Representative Doppler images are shown in Fig. 6. LVOT VTI was significantly decreased in MIchf compared with Sham at 5 and 7 days, whereas this was the case for peak LVOT flow only at 5 days (Table 4). CO in LVOT was overall significantly reduced in MIchf compared with Sham and at 5 days (47%). Peak RVOT flow was only significantly reduced in MIchf compared with Sham at 5 days, whereas RVOT VTI showed no significant differences.



View larger version (75K):
[in this window]
[in a new window]
 
Fig. 6. Doppler recordings. Representative Doppler tracings from the LV outflow tract (LVOT), right ventricular outflow tract (RVOT), and mitral positions. The scale in LVOT has been corrected for the angle between the ultrasound beam and the flow direction online. In the mitral position both the E and A waves are visible in Sham but are reduced and almost absent in MInf and MIchf. In many cases the E and A waves were fused.

 

View this table:
[in this window]
[in a new window]
 
Table 4. Doppler measurements

 
Mitral flow deceleration velocity (Mit dec) (Fig. 4C) was significantly increased in MIchf compared with Sham at all time points (37–44%) and compared with MInf at 7 days (39%). Peak mitral flow velocity showed an overall reduction in MIchf compared with Sham but was only significantly different at 7 days.

Inter- and intrascorer reliability.   To assess interscorer reliability, echocardiographic measurements were analyzed by two persons who were blinded for the intervention carried out. Also, one scorer analyzed the measurements twice, on separate days, to evaluate intrascorer reliability. LAD in 2D and M-mode, LVFS, PWSV, and Mit dec were evaluated in a subset of 10 mice. These parameters were chosen because they were considered the most central in describing either increased LV filling pressure, systolic function, or diastolic function. Both intra- and interscorer reliabilities were found acceptable with a mean difference <10% (Table 5). No statistically significant differences were found. Both the intra- and interscorer differences for LAD were as low as 0.00 ± 0.01 and 0.00 ± 0.02 mm, respectively, in both 2D and M-mode.


View this table:
[in this window]
[in a new window]
 
Table 5. Reproducibility of echocardiographic measurements

 
Parameters distinguishing MIchf from MInf and Sham at 7 days.   As seen in Fig. 7A, all MIchf animals had an infarct area >30% of total LV endocardial area, whereas that was the case for none in the MInf group. The average values for LV systolic pressure and LVEDP only separated the MIchf group from the Sham group, whereas LVdP/dtmax and LVdP/dtmin distinguished MIchf from both MInf and Sham (Table 2). However, the individual values for all of these parameters showed overlap between the groups (LVEDP illustrated in Fig. 7B). The noninvasive systolic parameter LVFS distinguished MIchf and MInf from Sham on an average basis, but MIchf and MInf were not significantly different. On an individual basis there was near-complete overlap between the values for LVFS in the MIchf and MInf groups and no overlap between MIchf and Sham, whereas one measurement in the MInf group overlapped with Sham (Fig. 7C). PWSV showed a significant difference between MIchf and both MInf and Sham. There was no overlap between the individual values for PWSV in the MIchf and Sham groups, but 5 of 10 measurements in the MInf group overlapped with MIchf and 5 of 10 in the MInf group overlapped with Sham. Another systolic parameter, LVDd, separated all of the groups with regard to average values and in addition distinguished every animal in the MIchf group from Sham. However, 1 out of 9 measurements in the MIchf group overlapped with MInf (Fig. 7D). The diastolic parameter Mit dec separated MIchf from both MInf and Sham on an average basis, whereas 1 of 7 measurements in the Sham group and 2 of 10 in the MInf group overlapped with MIchf (Fig. 7E). A fifth noninvasive parameter, LAD, distinguished MIchf from both MInf and Sham on an average basis and in addition showed no overlap for individual values (Fig. 7F). LAD in MInf was also significantly increased compared with Sham, but had considerable overlap.



View larger version (22K):
[in this window]
[in a new window]
 
Fig. 7. Scatterplots showing individual values at 7 days. Relationship between lung weights normalized to tibial length and infarct area measured by planimetry (A), left ventricular end-diastolic pressure (LVEDP; B), LVFS (C), LVDd (D), Mit dec (E), and left atrial diameter (LAD) measured in 2D (F). {circ}, MIchf; {triangleup}, MInf; {bullet}, Sham.

 

    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Echocardiography is a noninvasive method that can give serial and detailed information on in vivo cardiac function in mice. In this study we used a state-of-the-art, fully digital echocardiographic system with modified software to give sufficient time resolution to allow reliable 2D, M-mode, and Doppler measurements in mice. Echocardiographic measurements were compared with LV pressure recordings and infarct size calculations. On an individual basis, only infarct size and LAD were found to separate MIchf from MInf.

Systolic function.   We found that LV systolic function was markedly impaired in mice with MIchf. This was evidenced by a depression in LVFS compared with Sham already at 3 days. At 7 days we did not find a significant difference in LVFS between MIchf and MInf. PWSV measures the shortening velocity of viable myocardium in the posterior wall rather than the alterations in LV cavity dimensions measured by LVFS. In our study, mean PWSV in the MIchf groups were significantly lower than in Sham at all time points and also compared with MInf at 7 days. These results are in line with a previous study in postinfarction CHF rats (14).

Subsequent to MI, dilatation of the noninfarcted parts of the LV may follow, which is often accompanied by a shift of the pressure-volume curve to the right. LVDd is therefore related to LV systolic function, and both murine (11) and human (3, 5) studies have shown an increased LVDd in postinfarction CHF. LV dilatation is thought to reflect the increase in LV volume occurring as a compensatory mechanism to restore stroke volume at the early stages. Later it may, however, reflect decompensatory dilatation with hemodynamic deterioration. Gehrmann et al. (7) found that mice subjected to MI had increased apical LV diameters compared with Sham, as early as 24 h postinfarction, but did not investigate at later time points. Gao et al. (6), on the other hand, did not find any change in LVDd after 1 wk, but found an increase after 2.5 wk. Yang et al. (17) found that LVDd had increased after 1 wk and remained stable from 2 wk. The last study is in line with the present study, in which we found an increased LVDd in the MIchf groups compared with Sham as early as at 3 days, as well as a gradual increase until 14 days. Taken together, these studies suggest that LV diameter is increased early after the infarction, gradually dilates during the first 2 wk, and thereafter possibly remains stable.

Catheterization of the LV showed that LVdP/dtmax was reduced in MIchf compared with Sham at every time point measured, and LVdP/dtmax recorded in the MIchf group at 7 days showed a significant difference from both MInf and Sham. This fits with the reduction in PWSV found in MIchf. In agreement with our findings, Gao et al. (6) and Pons et al. (11) both found a reduction in LVdP/dtmax subsequent to MI, but in those studies they did not distinguish between MIchf and MInf.

Diastolic function.   Measuring LV filling patterns by echocardiography is often the preferred method for evaluating LV diastolic function (8, 10, 15). However, estimating the E/A ratio proved difficult in our study, because of fusion of the two waves in the mitral inflow signal in most of the mice. The separation of the E and A waves is heart rate dependent, and in the present study the waves fused at frequencies above ~400. On the other hand, our results showed a significant increase in average Mit dec in MIchf compared with Sham at all time points and also a large difference between MIchf and MInf at 7 days. This indicates impaired diastolic function in MIchf, but not in MInf. This parameter has not previously been examined in mice, but from human studies we know that an increase in early deceleration time is associated with reduced LV compliance (10, 15). Another echocardiographic parameter that assesses diastolic function, PWRV, was found to be not different in MIchf compared with MInf and Sham. Thus this parameter might be less sensitive to diastolic dysfunction than Mit dec. Another method used to evaluate relaxation velocities is tissue Doppler. However, this method has not been established in mice, probably because of insufficient time resolution. The invasive diastolic parameter, LVdP/dtmin, was significantly decreased in MIchf compared with MInf, as well as significantly different in the MIchf and Sham groups. This supports the presence of diastolic dysfunction in MIchf.

LVEDP and LAD.   The present investigation showed an increase in mean LVEDP in the MIchf groups compared with Sham, but no difference compared with MInf at 7 days. Also, others (9) have found significantly elevated LVEDP in mice with postinfarction heart failure compared with controls but have not distinguished MIchf from MInf. However, LV pressure measurements require cannulation of the right carotid artery, which prevents longitudinal studies. In addition, and especially in mice because of the relatively large catheter dimensions, catheterization may cause damage to the aortic valves and significantly affect cardiac performance. Furthermore, we found no indication that any of the invasive measures could discriminate between the groups any better than the noninvasive echocardiographic parameters, with regard to systolic and diastolic function.

LAD has not been measured in previous studies on mice. However, in humans the finding of an enlarged left atrium is consistent with a diagnosis of diastolic dysfunction (15). As shown in Table 3, mean LAD distinguished the MIchf group from both MInf and Sham and showed a significant increase with time at 7 and 14 days compared with 3 days. This may reflect gradually increasing left atrial pressure, or just a gradual distention of the atrium in response to an elevated but unchanged atrial pressure. When measured in 2D, LAD was larger in MInf than in Sham, despite no change in LW (Fig. 7F). This could be due to elevated atrial pressure in MInf subsequent to a slightly increased (37%) LV filling pressure compared with Sham. However, this rise in LV filling pressure may be insufficient to cause pulmonary congestion.

Echocardiographic method.   Echocardiographic descriptions of the murine postinfarction model have been carried out by others recently (1, 6, 11, 17, 18), but the equipment used has often had technical limitations. The depth of interest in the mouse is 0–10 mm, which is too short a distance for ordinary cardiac transducers to be able to focus on the relevant area. To achieve a suitable focus area, high-frequency vessel transducers have been used in previous studies. However, the frame rate was often too slow to truly sample systolic and diastolic frames in 2D. The fully digitized echocardiography system used in the present study had its software modified to allow recordings in 2D at >200 frames per second, which allows sampling of true end-systolic and end-diastolic frames. Also, the use of a 13-MHz transducer especially designed for studies in small rodents allowed for high-resolution imaging combined with a short focus distance (0 mm). These improvements resulted in high-quality recordings in 2D. Furthermore, we were able to analyze our data offline with the opportunity to adjust gain and time scale for optimal resolution. Adjustment of gain and time scale during post hoc analysis may reduce reproducibility compared with conventional analysis of printouts. However, we have shown that our reproducibility is within acceptable limits (Table 5).

Parameters discriminating MIchf, MInf, and Sham.   Most investigators agree that there is a gradual transition from asymptomatic compensated heart failure to decompensated symptomatic failure, but it is often difficult to assess the degree of failure in mice with MI. Previous studies on postinfarction mice have not discriminated between failing and nonfailing animals. In the present study, we evaluated an extensive list of parameters that could potentially be used as criteria for postinfarction MIchf. An increase in RVW normalized to body weight has previously been used as an indicator of CHF in the rat (4). Our results showing a significant increase in RVW/TL only at the two later time points could indicate that this parameter discriminates between early and later stages of CHF. However, there was overlap between individual values in the different groups at these time points. Furthermore, RVW will only increase in cases with substantially elevated pressure in the pulmonary circulation. In cases with only modest pulmonary congestion, the pressure in arteria pulmonalis does not increase enough to result in an increase in RVW (3). Thus increased RVW is not a prerequisite for a diagnosis of pulmonary congestion. All MIchf animals had an infarct area >30% of the LV area, whereas none in the MInf group had infarcts that were that large (Fig. 7A). Although measuring infarct area discriminates well on an individual basis, it is, however, terminally invasive. On the other hand, we found that estimating infarct size as percentage of total LV circumference measured noninvasively by 2D echocardiography also discriminated every MIchf animal from the MInf group. All MIchf animals were found to have an infarct >40% of the LV circumference. Although moderately overestimated compared with planimetric measurements of infarct area, the data obtained by the two different methods showed a reasonably good correlation, and therefore one could argue that this might be a very useful parameter for classifying the mice.

Mean LVFS separated both MIchf and MInf from Sham, and there was only one individual result in the MInf group that overlapped with Sham. However, there was an almost complete overlap between individual results in the MIchf and MInf groups, making this parameter unsuited for categorizing the mice. We found that, although LVDd distinguished MIchf, MInf, and Sham well on an average basis, individual values from all three groups overlapped to a certain degree. Sjaastad et al. (14) found that PWSV managed to separate all MIchf from MInf in the rat, but in our investigation there was an overlap between individual measurements in the MIchf and MInf groups. This indicates that PWSV may not be used as a criterion for postinfarction MIchf in mice, even though it can in rats. Of the diastolic parameters, mean Mit dec in MIchf was significantly different from both MInf and Sham and was the parameter best able to separate MIchf from the other groups. However, Mit dec did not separate individual animals in the MIchf group from MInf and Sham. LVdP/dtmin was decreased in MIchf compared with Sham at all time points, and MInf was different from MIchf and Sham. There was, however, overlap between LVdP/dtmin values in all three groups at 7 days. In larger animals, such as rats, LAD has been shown to discriminate between animals with and without heart failure (14). In agreement with this, we found that LAD could on an individual basis completely distinguish MIchf from MInf and Sham. Furthermore, we found this parameter to have a high degree of reliability, judged by a small inter- and intraobserver variability and a high correlation between measurements obtained in 2D and M-mode. For these reasons, we suggest that it is feasible to use this noninvasive measure as a main criterion for postinfarction CHF.

Limitations of the study.   This investigation was carried out under specific experimental conditions, including a degree of sedation, certain age of the mice, and certain time from induction of infarction.

In conclusion, our study showed that the systolic parameters LVdP/dtmax, LVFS, and PWSV were decreased in MIchf compared with Sham at all time points investigated. We also found that the diastolic parameters Mit dec and LVdP/dtmin differed significantly in MIchf compared with Sham at all time points. Only LAD and infarct size could distinguish all MIchf animals from both Sham and MInf. We therefore suggest that a significantly increased LAD and infarct size >40% of total LV circumference may serve as major criteria for postinfarction CHF in the mouse.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
This work has been supported by the Norwegian Research Council, Anders Jahre's Fund for the Promotion of Science, Rakel and Otto Kr. Bruun's fund, and the Ullevaal University Hospital Fund.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
We gratefully acknowledge Line Solberg, Carsten Lund, and Morten Eriksen for animal care, and Tævje A. Strømme for technical assistance with the pressure measurements.


    FOOTNOTES
 

Address for reprint requests and other correspondence: A. V. Finsen, Institute for Experimental Medical Research, Ullevaal Univ. Hospital, Kirkeveien 166, N-0407 Oslo, Norway (E-mail: a.v.finsen{at}medisin.uio.no)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 

  1. Bayat H, Swaney JS, Ander AN, Dalton N, Kennedy BP, Hammond HK, and Roth DM. Progressive heart failure after myocardial infarction in mice. Basic Res Cardiol 97: 206–213, 2002.[CrossRef][Web of Science][Medline]
  2. Bland JM and Altman DG. Statistical-methods for assessing agreement between 2 methods of clinical measurement. Lancet 1: 307–310, 1986.[CrossRef][Web of Science][Medline]
  3. Colucci WS and Braunwald E. Pathophysiology of heart failure. In: Heart Disease, edited by Braunwald E, Zipes DP, and Libby P. Philadelphia, PA: Saunders, 2001, chapt. 16, p. 503–534.
  4. Diederich ER, Behnke BJ, McDonough P, Kinding CA, Barstow TJ, Poole DC, and Musch TI. Dynamics of microvascular oxygen partial pressure in contracting skeletal muscle of rats with chronic heart failure. Cardiovasc Res 56: 479–486, 2002.[Abstract/Free Full Text]
  5. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, and Weisfeldt ML. Regional cardiac dilatation after acute myocardial-infarction-recognition by 2-dimensional echocardiography. N Engl J Med 300: 57–62, 1979.[Abstract]
  6. Gao XM, Dart AM, Dewar E, Jennings G, and Du XJ. Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice. Cardiovasc Res 45: 330–338, 2000.[Abstract/Free Full Text]
  7. Gehrmann J, Frantz S, Maguire CT, Vargas M, Ducharme A, Wakimoto H, Lee RT, and Berul CI. Electrophysiological characterization of murine myocardial ischemia and infarction. Basic Res Cardiol 96: 237–250, 2001.[CrossRef][Web of Science][Medline]
  8. Hogg K, Swedberg K, and McMurray J. Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43: 317–327, 2004.[Abstract/Free Full Text]
  9. Kinugawa S, Tsutsui H, Hayashidani S, Ide T, Suematsu N, Satoh S, Utsumi H, and Takeshita A. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res 87: 392–398, 2000.[Abstract/Free Full Text]
  10. Little WC. Assessment of normal and abnormal cardiac function. In: Heart Disease, edited by Braunwald E, Zipes DP, and Libby P. Philadelphia, PA: Saunders, 2001, chapt. 15, p. 479–503.
  11. Pons S, Fornes P, Hagege AA, Heudes D, Giudicelli JF, and Richer C. Survival, haemodynamics and cardiac remodeling follow up in mice after myocardial infarction. Clin Exp Pharmacol Physiol 30: 25–31, 2003.[CrossRef][Web of Science][Medline]
  12. Rodevand O, Bjornerheim R, Aakhus S, and Kjekshus J. Left ventricular volumes assessed by different new three-dimensional echocardiographic methods and ordinary biplane technique. Int J Card Imaging 14: 55–63, 1998.[CrossRef][Web of Science][Medline]
  13. Scherrer-Crosbie M, Steudel W, Hunziker PR, Liel-Cohen N, Ullrich R, Zapol WM, and Picard MH. Three-dimensional echocardiographic assessment of left ventricular wall motion abnormalities in mouse myocardial infarction. J Am Soc Echocardiogr 12: 834–840, 1999.[CrossRef][Web of Science][Medline]
  14. Sjaastad I, Sejersted OM, Ilebekk A, and Bjornerheim R. Echocardiographic criteria for detection of postinfarction congestive heart failure in rats. J Appl Physiol 89: 1445–1454, 2000.[Abstract/Free Full Text]
  15. Smiseth OA. Assessment of ventricular diastolic function. Can J Cardiol 17: 1167–1176, 2001.[Web of Science][Medline]
  16. Woldbaek PR, Hoen IB, Christensen G, and Tonnessen T. Gene expression of colony-stimulating factors and stem cell factor after myocardial infarction in the mouse. Acta Physiol Scand 175: 173–181, 2002.[CrossRef][Web of Science][Medline]
  17. Yang F, Liu YH, Yang XP, Xu J, Kapke A, and Carretero OA. Myocardial infarction and cardiac remodeling in mice. Exp Physiol 87: 547–555, 2002.[Abstract]
  18. Yang XP, Liu YH, Rhaleb NE, Kurihara N, Kim HE, and Carretero OA. Echocardiographic assessment of cardiac function in conscious and anesthetized mice. Am J Physiol Heart Circ Physiol 277: H1967–H1974, 1999.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. K. Mork, I. Sjaastad, O. M. Sejersted, and W. E. Louch
Slowing of cardiomyocyte Ca2+ release and contraction during heart failure progression in postinfarction mice
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1069 - H1079.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Krishnamurthy, J. Rajasingh, E. Lambers, G. Qin, D. W. Losordo, and R. Kishore
IL-10 Inhibits Inflammation and Attenuates Left Ventricular Remodeling After Myocardial Infarction via Activation of STAT3 and Suppression of HuR
Circ. Res., January 30, 2009; 104(2): e9 - e18.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
A Schumacher, E. Khojeini, and D. Larson
ECHO parameters of diastolic dysfunction
Perfusion, September 1, 2008; 23(5): 291 - 296.
[Abstract] [PDF]


Home page
PerfusionHome page
A Platis, Q Yu, D Moore, E. Khojeini, P Tsau, and D. Larson
The effect of daily administration of IL-18 on cardiac structure and function
Perfusion, July 1, 2008; 23(4): 237 - 242.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Guazzi, R. Arena, and M. D. Guazzi
Evolving changes in lung interstitial fluid content after acute myocardial infarction: mechanisms and pathophysiological correlates
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1357 - H1364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. Subramanian, P. Krishnamurthy, K. Singh, and M. Singh
Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H673 - H683.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P Krishnamurthy, V Subramanian, M Singh, and K Singh
Deficiency of {beta}1 integrins results in increased myocardial dysfunction after myocardial infarction
Heart, September 1, 2006; 92(9): 1309 - 1315.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K.-O. Larsen, I. Sjaastad, A. Svindland, K. A. Krobert, O. H. Skjonsberg, and G. Christensen
Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H507 - H516.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
W. E. Louch, H. K. Mork, J. Sexton, T. A. Stromme, P. Laake, I. Sjaastad, and O. M. Sejersted
T-tubule disorganization and reduced synchrony of Ca2+ release in murine cardiomyocytes following myocardial infarction
J. Physiol., July 15, 2006; 574(2): 519 - 533.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
98/2/680    most recent
00924.2004v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finsen, A. V.
Right arrow Articles by Sjaastad, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finsen, A. V.
Right arrow Articles by Sjaastad, I.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.